The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor‐α inhibitor

BACKGROUND AND AIM: Tacrolimus (TAC) is an important therapeutic option for remission induction in patients with refractory ulcerative colitis (UC). However, there is little evidence available on long‐term outcomes and maintenance treatments after TAC therapy, especially in cases with previous tumor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JGH Open
Autors principals: Suzuki, Taketo, Mizoshita, Tsutomu, Tanida, Satoshi, Sugimura, Naomi, Katano, Takahito, Nishie, Hirotada, Kataoka, Hiromi
Format: Artigo
Idioma:Inglês
Publicat: Wiley Publishing Asia Pty Ltd 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6586576/
https://ncbi.nlm.nih.gov/pubmed/31276039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12140
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars